Hide Board Information

Show Board Information

Arqit Quantum Inc. ARQQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/08/2022 4:50:37 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Arqit Quantum Inc. (NASDAQ: ARQQ) Stock Message Board

1. ARQQ Company Profile

    

2. ARQQ Time & Sales

    

3. ARQQ Recent News

    

4. ARQQ Filings

    

5. ARQQ Financials

    

6. ARQQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$ARQQ 24% v4,2M c10.26 f121,9M H10.39 ML3.8	znewcar1	11/08/2022 4:50:37 PM
5	$ARQQ 46% v4,0M c8.21 f121,9M H8.40	znewcar1	11/07/2022 10:26:37 PM
4	ARQQ 38% v7,8M c7.72 f121,9M H7.95	znewcar1	09/12/2022 10:01:20 PM
3	ARQQ 22% v1,1M C15.63 f120MH16.13 YL12.66	znewcar1	03/14/2022 4:21:35 PM
2	ARQQ 21% v1,4M c19.92 f120M	znewcar1	12/17/2021 11:19:41 PM
1	ARQQ 21% v1,47M c21.87 f120M	znewcar1	10/29/2021 10:57:06 PM

Recent Articles

• Wolters Kluwer Announces Successful Share Buyback Plans
• Elimini and HOFOR Collaborate on Groundbreaking CO2 Capture Project
• Innovations Shaping the Future of Catering Equipment Market
• Exclusive Bentley Home Residences Launch in Stunning Marbella
• Navigating Trump’s Ambitious $750 Billion Energy Venture
• How Shared Play Enhances Family Emotional Bonds and Connections
• Bentley Home Partners with RGZ Developers for Luxury Residences
• WuXi Biologics Launches New Modular Facility to Enhance Production
• Elimini and HOFOR Form Key Agreements for CO2 Reduction Efforts
• Exploring the Role of Shared Play in Strengthening Family Bonds
• Enhancing M&A Success: New Insights for Tech Advisors
• Luxury Living Group Partners with RGZ Developers in Marbella
• Aon Study Highlights Need for Personalized Employee Benefits
• Navigating the Fed's Monetary Policy Challenges: Act or Delay?
• Volatile Trading Session Highlights EU-US Deal Impact on Markets
• MetrioPharm Celebrates EMA Orphan Drug Status for MP1032 in DMD
• Natural Catastrophes: The Ongoing Challenge for Insurers Ahead
• Bitcoin Swift's Exciting Presale Phase Nears Its Conclusion
• Jupiter Fund Management and Renold plc Positions Disclosure
• Key Innovations in Catering Equipment Ahead of HOTELEX 2026
• Ericsson Finalizes Joint Venture with Aduna for Network APIs
• Reviving the $1 Memecoin: A Community Stands Against Inflation
• Understanding the Upcoming Riksbank Certificate Auction Process
• Nokia Corporation Reports Recent Share Acquisition by Manager
• Nokia Corporation Reports Transactions in Senior Management
• Man Group PLC: A Deep Dive into Recent Securities Disclosure
• U.S. Treasury's Bold $1 Trillion Borrowing Plan Explained
• Theta Capital Hosts Legends4Legends 2025 Blockchain Event
• Baidu Wenku's Remarkable Growth in AI-Powered Presentations
• Exploring Snow Jiang's Vision for Global Pop Music Success
• Ericsson Finalizes Strategic Partnership in Aduna Venture
• Ransomware Hits New Heights: Key Insights from Zscaler Report
• Liqxtal's Pro-Eye Monitor Shines in Age-Friendly Tech Awards
• MemorialCare Hospitals Honored for High-Performing Care Options
• Exploring Opportunities for the Visually Impaired Workforce
• Quest Global and Andretti Formula E Unite for Motorsport Innovation
• FOMC's Rate Decision: Balancing Inflation and Economic Signals
• Market Trends Revealing Challenges Amidst Record Gains
• Brandt Hospitality Group Welcomes Back Holiday Inn Properties
• Innovations in RNA Therapeutics Explored at Tsingke Roundtable
• Savyint Partners with IDEX for Innovative Biometric Solutions
• Ontex Group NV Shares: A Significant Voting Rights Update
• Atari's Strategic Investment in Thunderful Group Unveiled
• Key Insights on Bank Millennium's H1 Performance in 2025
• NVIDIA Achieves Historic $4.3 Trillion Valuation Amid AI Boom
• AudioCodes Reports Q2 2025 Financial Results & Dividend
• Stellantis H1 2025 Financial Results Show Recovery Efforts
• Starbucks and Univers Team Up for Revolutionary Green Changes
• Tsingke Biotech's Roundtable Advances Nucleic Acid Therapies
• Tata Elxsi and KAVIA AI Unite for Next-Gen SDLC Automation